Correlation Between Illumina and PharmChem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Illumina and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Illumina and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Illumina and PharmChem, you can compare the effects of market volatilities on Illumina and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Illumina with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Illumina and PharmChem.

Diversification Opportunities for Illumina and PharmChem

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Illumina and PharmChem is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Illumina and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Illumina is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Illumina are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Illumina i.e., Illumina and PharmChem go up and down completely randomly.

Pair Corralation between Illumina and PharmChem

Given the investment horizon of 90 days Illumina is expected to generate 2.27 times more return on investment than PharmChem. However, Illumina is 2.27 times more volatile than PharmChem. It trades about 0.24 of its potential returns per unit of risk. PharmChem is currently generating about -0.18 per unit of risk. If you would invest  13,074  in Illumina on September 17, 2024 and sell it today you would earn a total of  1,331  from holding Illumina or generate 10.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Illumina  vs.  PharmChem

 Performance 
       Timeline  
Illumina 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Illumina are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating primary indicators, Illumina displayed solid returns over the last few months and may actually be approaching a breakup point.
PharmChem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Illumina and PharmChem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Illumina and PharmChem

The main advantage of trading using opposite Illumina and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Illumina position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.
The idea behind Illumina and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges